Examining patient-specific responses to PARP inhibitors in a novel, human induced pluripotent stem cell-based model of breast cancer. - Weddle CJ; Blancard M; Uche N; Pongpamorn P; Cejas RB; Burridge PW (NPJ precision oncology, 2025)